Effects of valproate, carbamazepine, and levetiracetam on the antioxidant and oxidant systems in epileptic patients and their clinical importance

Clinical Neuropharmacology

Volumn 33, Issue 3, 2010, Pages 155-157

  Varoglu, Asuman Orhan ^a   Yildirim, Abdulkadir ^a   Aygul, Recep ^a   Gundogdu, Omer Lutfi ^a   Sahin, Yasar Nuri ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

8 hydroxyguanine; Antiepileptic drugs; Arylesterase; Oxidized LDL; Paraoxonase

Indexed keywords

8 HYDROXYGUANINE; ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; CARBAMAZEPINE; ETIRACETAM; OXIDIZED LOW DENSITY LIPOPROTEIN; VALPROIC ACID;

ADOLESCENT; ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EPILEPSY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ADOLESCENT; ADULT; ANTICONVULSANTS; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; CARBAMAZEPINE; CARBOXYLIC ESTER HYDROLASES; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; GUANINE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; PIRACETAM; VALPROIC ACID; YOUNG ADULT;

EID: 77953228720     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3181d1e133     Document Type: Article

References (14)

1. Sies H, Cadenas E. Oxidative stress: damage to intact cells and organs. Philos Trans R Soc Lond B Biol Sci 1985;311(1152):617-631.
2. Kutluhan S, Naziro?lu M, Celik O, et al. Effects of selenium and topiramate on lipid peroxidation and antioxidant vitamin levels in blood of pentylentetrazol-induced epileptic rats. Biol Trace Elem Res 2009;129 (1-3) : 181-189.
3. Karikas GA, Schulpis KH, Bartzeliotou A, et al. Early effects of sodium valproate monotherapy on serum paraoxonase/arylesterase activities. Scand J Clin Lab Invest 2009;69(1):31-35.
4. Charlton-Menys V, Liu Y, Durrington PN. Semiautomated method for determination of serum paraoxonase activity using paraoxon as substrate. Clin Chem 2006;52(3):453-457.
5. Eckerson HW, Wyte CM, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983;35(6):1126-1138.
6. Kaur H, Halliwell B. Measurement of oxidized and methylated DNA bases by HPLC with electrochemical detection. Biochem J 1996;318:21-23.
7. Tsurudome Y, Hirano T, Yamato H, et al. Changes in levels of 8-hydroxyguanine in DNA, its repair and OGG1 mRNA in rat lungs after intratracheal administration of diesel exhaust particles. Carcinogenesis 1999;20(8):1573-1576.
8. Freitas RM. Investigation of oxidative stress involvement in hippocampus in epilepsy model induced by pilocarpine. Neurosci Lett 2009;462(3):225-229.
9. Verrotti A, Scardapane A, Franzoni E, et al. Increased oxidative stress in epileptic children treated with valproic acid. Epilepsy Res 2008;78 (2-3) : 171-177.
10. Uma Devi P, Pillai KK, Vohora D. Modulation of pentylenetetrazole-induced seizures and oxidative stress parameters by sodium valproate in the absence and presence of N-acetylcysteine. Fundam Clin Pharmacol 2006;20(3):247-253.
11. Schulpis KH, Lazaropoulou C, Regoutas S, et al. Valproic acid monotherapy induces DNA oxidative damage. Toxicology 2006;217 (2-3) : 228-232.
12. Ono H, Sakamoto A, Sakura N. Plasma total glutathione concentrations in epileptic patients taking anticonvulsants. Clin Chim Acta 2000;298 (1-2) : 135-143.
13. Ueda Y, Doi T, Takaki M, et al. Levetiracetam enhances endogenous antioxidant in the hippocampus of rats: in vivo evaluation by brain microdialysis combined with ESR spectroscopy. Brain Res 2009;1266:1-7.
14. Tong V, Teng XW, Chang TK, et al. Valproic acid I: time course of lipid peroxidation biomarkers, liver toxicity, and valproic acid metabolite levels in rats. Toxicol Sci 2005;86(2):427-435.